Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

1.20
+0.08007.14%
Post-market: 1.15-0.0500-4.17%19:38 EST
Volume:78.09K
Turnover:90.26K
Market Cap:14.53M
PE:0.25
High:1.21
Open:1.12
Low:1.09
Close:1.12
52wk High:9.71
52wk Low:0.3750
Shares:12.11M
Float Shares:8.66M
Volume Ratio:1.02
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.87
EPS(LYR):77.74
ROE:--
ROA:-165.52%
PB:-0.73
PE(LYR):0.02

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
AMEX
Establishment Date:
- -
Employees:
5
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.